SCHEMBL30263272

SCHEMBL30263272

Nc1nc(-c2ccccc2Br)cs1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 1.00
MPL P40238 3/20 0.62
ALDH1A1 P00352 7/20 0.55
RAB9A P51151 9/20 0.52
MAPT P10636 8/20 0.52
NPC1 O15118 7/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
KDM4E B2RXH2 3/20 0.52
LMNA P02545 2/20 0.52
NFKB1 P19838 2/20 0.52
NFKB2 Q00653 2/20 0.52
RELA Q04206 2/20 0.52
CYP3A4 P08684 2/20 0.52
HPGD P15428 1/20 0.50
HK1 P19367 1/20 0.50
HKDC1 Q2TB90 1/20 0.50
THRB P10828 1/20 0.50
ALOX15 P16050 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL39119 1.00 HSD17B10 (1.00) HSD17B10MPLALDH1A1RAB9AMAPT
SCHEMBL12592152 0.80 HSD17B10 (0.67) HSD17B10MPLALDH1A1RAB9AMAPT
SCHEMBL4367505 0.80 HSD17B10 (0.67) HSD17B10MPLALDH1A1RAB9AMAPT
SCHEMBL4398658 0.79 HSD17B10 (0.66) HSD17B10MPLALDH1A1RAB9AMAPT
SCHEMBL19626487 0.79 HSD17B10 (0.66) HSD17B10MPLALDH1A1RAB9AMAPT
SCHEMBL31052414 0.78 HSD17B10 (0.64) HSD17B10MPLALDH1A1RAB9AMAPT
SCHEMBL44739 0.77 MPL (1.00) HSD17B10MPLALDH1A1RAB9AMAPT
SCHEMBL3835119 0.77 HSD17B10 (0.62) HSD17B10MPLALDH1A1RAB9AMAPT
SCHEMBL8359999 0.77 HSD17B10 (0.62) HSD17B10MPLALDH1A1RAB9AMAPT
SCHEMBL6686670 0.77 TYR (0.66) HSD17B10MPLALDH1A1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025129104-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF SIONNA THERAPEUTICS INC. (US) 2025-06-19 WO disclosed
EP-4161921-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF Anima Biotech Inc. (US) 2023-04-12 EP disclosed
CN-115916776-A Collagen 1 translation inhibitors and methods of use thereof 艾尼莫生物科技公司 2023-04-04 CN disclosed